San Diego, CA — March 11, 2026: Shares of genomics giant Illumina (NASDAQ: ILMN) have surged a remarkable 44.8% over the past...
Pharmaceutical giant Pfizer has quietly positioned itself to challenge industry leaders in the high-stakes obesity drug race. This strategic maneuver could potentially...